VirusArchives
Trajectories of health-related quality of life among people with HIV within five years of diagnosis
Virus 5 min.
By the end of 2024, an estimated 1.35 million individuals in China were living with human immunodeficiency virus (HIV), highlighting its status as a major public health concern [1]. Since the launch and expansion of the National Free Antiretroviral Treatment Program in 2002, access to antiretroviral...
K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming
Virus 11 min.
Since 2020, the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has heavily affected the lives of people all around the world. Despite the development of efficacious vaccines, surveillance systems, and personal protective equipment reducing the spread of infection,...
Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021–2024
Virus 6 min.
Vaccination against the coronavirus disease 2019 (COVID-19) and natural infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can each induce immunological protection against SARS-CoV-2 infection. The combined protection is known as hybrid immunity. High incidence of SARS-CoV-2...
Neurodevelopmental Outcomes of 3-Year-Old Children Exposed to Maternal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Utero.
Virus 1 min.
To determine whether in utero exposure to maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased risk of adverse neurodevelopmental outcomes in children by age 3 years. METHODS: We conducted a retrospective cohort study of 18,124 live births to individuals...
Leveraging injection networks to prevent HIV and other blood borne infections among people who inject drugs in Kenya: design and rationale
Virus 7 min.
There are approximately 14.8 million people who inject drugs (PWID) worldwide, with an estimated 38.8% (or 5.8 million) living with hepatitis C (HCV), 15.2% (or 2.3 million) living with HIV, and 8.4% (or 1.2 million) living with hepatitis B (HBV) [1]. Between 2010 and 2022, annual new HIV infections...
